Varicella: is it time for a global vaccination programme?
Eva Louise Wooding1,2, Seilesh Kadambari3,4, Adilia Warris3
1MRC Centre for Medical Mycology, Exeter, UK evawooding@nhs.net.
Archives of Disease in Childhood
|February 20, 2025
Summary
Chickenpox (varicella zoster virus) vaccination significantly reduces disease burden, especially in children. Two-dose regimens further decrease shingles risk, though long-term impacts and cost-effectiveness in lower-resource settings require more study.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Varicella, or chickenpox, is a viral illness caused by the varicella zoster virus (VZV), affecting millions globally each year.
- While often self-limiting in children, VZV causes significant disability-adjusted life years, disproportionately impacting lower-income regions and posing risks to immunocompromised individuals and neonates.
- Disease epidemiology differs geographically, with earlier onset in temperate climates compared to tropical regions.
Purpose of the Study:
- To review the epidemiology of varicella and the impact of vaccination programs.
- To assess the effectiveness of varicella vaccination, including single and two-dose regimens (alone or as MMRV).
- To evaluate the cost-effectiveness of varicella vaccination and identify areas for future research.
Main Methods:
- Review of existing epidemiological data on varicella zoster virus (VZV) incidence and burden.
- Analysis of data from countries with universal varicella vaccination programs (single or two-dose, monovalent or MMRV).
- Examination of cost-effectiveness studies in high-resource settings and identification of research gaps for lower-resource regions.
Main Results:
- Over 40 countries utilize universal varicella vaccination, demonstrating reduced cases and hospitalizations.
- Two-dose regimens are more effective at preventing breakthrough infections and may reduce shingles incidence.
- Vaccination is cost-effective in high-resource settings, but feasibility and cost-effectiveness in lower-resource areas need further investigation.
Conclusions:
- Varicella vaccination is a key strategy for reducing disease burden, with two-dose schedules offering enhanced protection against VZV and shingles.
- While global elimination is challenging, vaccination significantly mitigates varicella's impact based on regional factors.
- Further research is crucial to optimize vaccination strategies, particularly in resource-limited settings, and to understand long-term shingles incidence.
Related Concept Videos
Vaccinations
43.7K
Overview
43.7K
Cross-reactivity
30.9K
Overview
30.9K
Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325


